Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Phytoserms for Menopause Symptoms and Age-Associated Memory Decline (phytoSERM)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2012 by University of Southern California.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
University of Southern California Identifier:
First received: November 6, 2012
Last updated: November 7, 2012
Last verified: November 2012

The purpose of this study is to evaluate the safety and efficacy of a soy based dietary supplement (phytoSERM) for hot flashes and age associated memory loss.

Condition Intervention
Hot Flashes
Memory Loss
Dietary Supplement: PhytoSERM tablet
Dietary Supplement: placebo

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Official Title: Estrogen Receptor-beta phytoSERMs for Management of Menopause and Age-Associated Memory Decline

Resource links provided by NLM:

Further study details as provided by University of Southern California:

Primary Outcome Measures:
  • safety and tolerability [ Time Frame: 12 weeks ] [ Designated as safety issue: Yes ]
    as measured by assessment of AEs, co-morbid events, laboratory measures, symptoms and cognitive performance

  • efficacy [ Time Frame: 12 weeks ] [ Designated as safety issue: Yes ]
    change from baseline in neuropsychological (cognitive, functional) test results

  • efficacy [ Time Frame: 12 weeks ] [ Designated as safety issue: Yes ]
    change from baseline in vasomotor symptoms

Estimated Enrollment: 78
Study Start Date: July 2012
Estimated Study Completion Date: September 2013
Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: PhytoSERM 50 mg tablet
Dietary supplement: PhytoSERM tablet to be taken once per day for 12 weeks
Dietary Supplement: PhytoSERM tablet
Experimental: PhytoSERM 100 mg tablet
Dietary supplement: PhytoSERM tablet to be taken once per day for 12 weeks
Dietary Supplement: PhytoSERM tablet
Placebo Comparator: Placebo tablet
Dietary supplement: placebo tablet to be taken once per day for 12 weeks
Dietary Supplement: placebo


Ages Eligible for Study:   48 Years to 58 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • post-menopausal women
  • ages 48 - 58 (inclusive)
  • must have a vasomotor symptom (e.g., hot flash) and a memory complaint

Exclusion Criteria:

  • history of clinically significant stroke
  • current evidence or history in past 2 years of epilepsy, seizure, focal brain lesion, head injury with loss of consciousness or any major psychiatric disorder including psychosis, major depression, bipolar disorder, alcohol or substance abuse
  • Known allergy to soy derived products; hypersensitivity to estrogens or progestins
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01723917

United States, California
USC Keck School of Medicine Recruiting
Los Angeles, California, United States, 90033
Contact: Gerson Hernandez, MD    323-442-5775   
Contact: Nadine Diaz, MSW    (323) 442-5775   
Principal Investigator: Lon Schneider, MD         
Sponsors and Collaborators
University of Southern California
Principal Investigator: Lon S Schneider, MD University of Southern California
  More Information

No publications provided

Responsible Party: University of Southern California Identifier: NCT01723917     History of Changes
Other Study ID Numbers: AG033288, R01AG033288
Study First Received: November 6, 2012
Last Updated: November 7, 2012
Health Authority: United States: Data and Safety Monitoring Board
United States: Institutional Review Board processed this record on November 24, 2014